CLINICAL_TRIALS
trial_result
· 2013-08-29
Clinical Trial Update: A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes [Phase 1]
Summary
Pfizer reported results from a Phase 1 trial of PF-04991532 in adults with Type 2 diabetes; the study is completed and results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2013-08-29